Last updated: July 17, 2026

Application No. 18/724,209

FUSED BICYCLIC HETEROARYL AMIDE COMPOUND AS PROTEIN AGGREGATION INHIBITOR

Non-Final OA

Filed

Jun 26, 2024

Priority

Dec 27, 2021 — CN 202111615487.0 +1 more

Examiner

CHANDRAKUMAR, NIZAL S

Art Unit

Tech Center

Assignee

Zhejiang Jingxin Pharmaceutical Co. Ltd.

OA Round

1 (Non-Final)

Interview Optional

— +18.3% interview lift. Examiner has a relatively high allowance rate (73%); +18.3% interview lift. A written response may suffice.

Based on 1768 resolved cases, 2023–2026

Examiner Intelligence

CHANDRAKUMAR, NIZAL S View full profile →

Grants 73% — above average

Career Allowance Rate

1284 granted / 1768 resolved

+12.6% vs TC avg

Strong +18% interview lift

Without

With

+18.3%

Interview Lift

resolved cases with interview

Typical timeline

2y 3m

Avg Prosecution

89 currently pending

Career history

1858

Total Applications

across all art units

Statute-Specific Performance

§101

1.6%

-38.4% vs TC avg

§103

33.5%

-6.5% vs TC avg

§102

6.6%

-33.4% vs TC avg

§112

37.9%

-2.1% vs TC avg

Black line = Tech Center average estimate • Based on career data from 1768 resolved cases

Prosecution Timeline

Jun 26, 2024

Application Filed

Jun 05, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

18/222,153

Patent 12678466

Method to Improve Therapeutic Properties of Stem Cells

3y 0m to grant Granted Jul 14, 2026

17/259,632

Patent 12673928

PROCESS FOR THE PRODUCTION AND SEPARATION OF 5-HYDROXYMETHYLFURFURAL WITH QUATERNARY AMMONIUM SALTS

5y 5m to grant Granted Jul 07, 2026

17/050,042

Patent 12667619

INTEGRIN TARGETING LIGANDS AND USES THEREOF

5y 8m to grant Granted Jun 30, 2026

18/117,328

Patent 12661316

CREATINE AND/OR CREATININE COMPOSITIONS AND RELATED METHODS

3y 3m to grant Granted Jun 23, 2026

18/002,932

Patent 12653818

PHARMACEUTICAL COMPOSITIONS COMPRISING NITROXOLINE LYSINATE, PREPARATION METHOD THEREFOR AND USE THEREOF

3y 5m to grant Granted Jun 16, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

73%

Grant Probability

91%

With Interview (+18.3%)

2y 3m (~2m remaining)

Median Time to Grant

Low

PTA Risk

Based on 1768 resolved cases by this examiner. Grant probability derived from career allowance rate.